GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q BioMed Inc (OTCPK:QBIO) » Definitions » Total Assets

Q BioMed (Q BioMed) Total Assets : $3.47 Mil (As of Feb. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Q BioMed Total Assets?

Q BioMed's Total Assets for the quarter that ended in Feb. 2023 was $3.47 Mil.

Total Assets is connected with ROA %. Q BioMed's annualized ROA % for the quarter that ended in Feb. 2023 was -82.74%. Total Assets is also linked to Revenue through Asset Turnover. Q BioMed's Asset Turnover for the quarter that ended in Feb. 2023 was 0.00.


Q BioMed Total Assets Historical Data

The historical data trend for Q BioMed's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q BioMed Total Assets Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.20 0.64 0.62 0.81 3.52

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.47 0.50 3.52 3.47

Q BioMed Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Q BioMed's Total Assets for the fiscal year that ended in Nov. 2022 is calculated as

Total Assets=Total Equity (A: Nov. 2022 )+Total Liabilities (A: Nov. 2022 )
=-4.617+8.133
=3.52

Q BioMed's Total Assets for the quarter that ended in Feb. 2023 is calculated as

Total Assets=Total Equity (Q: Feb. 2023 )+Total Liabilities (Q: Feb. 2023 )
=-6.441+9.906
=3.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q BioMed  (OTCPK:QBIO) Total Assets Explanation

Total Assets is connected with ROA %.

Q BioMed's annualized ROA % for the quarter that ended in Feb. 2023 is

ROA %=Net Income (Q: Feb. 2023 )/( (Total Assets (Q: Nov. 2022 )+Total Assets (Q: Feb. 2023 ))/ count )
=-2.888/( (3.516+3.465)/ 2 )
=-2.888/3.4905
=-82.74 %

Note: The Net Income data used here is four times the quarterly (Feb. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Q BioMed's Asset Turnover for the quarter that ended in Feb. 2023 is

Asset Turnover
=Revenue (Q: Feb. 2023 )/( (Total Assets (Q: Nov. 2022 )+Total Assets (Q: Feb. 2023 ))/ count )
=0/( (3.516+3.465)/ 2 )
=0/3.4905
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Q BioMed Total Assets Related Terms

Thank you for viewing the detailed overview of Q BioMed's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Q BioMed (Q BioMed) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
Executives
William S Rosenstadt director, 10 percent owner, officer: Chief Legal Officer ORTOLI ROSENSTADT LLP, 501 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022
Denis Corin director, 10 percent owner, officer: Chief Executive Officer 10 MARKET STREET, SUITE 427, GRAND CAYMAN E9 KY1-9006
Rick Panicucci director 501 MADISON STREET, 14TH FLOOR, NEW YORK NY 10022
Alan P Lindsay 10 percent owner 580 HORNBY STREET, FIFTH FLOOR, VANCOUVER BC CANADA V6C 2E7 A1